ClearPoint Neuro, Inc., headquartered in Solana Beach, California, is a medical device company that primarily operates in the United States. The company specializes in developing and commercializing platforms for performing minimally invasive surgical procedures in the brain, offering the ClearPoint system for deep brain stimulation electrode insertion, biopsy needle insertion, and the infusion of pharmaceuticals and laser catheters. Their technology utilizes direct and intra-procedural magnetic resonance imaging (MRI) guidance. ClearPoint Neuro has established license and collaboration agreements with Clinical Laserthermia Systems AB, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California and San Francisco. The company was previously known as MRI Interventions, Inc. but officially changed its name to ClearPoint Neuro, Inc. in February of 2020. With over 20 years of experience in the industry, ClearPoint Neuro, Inc. continues to operate as a leading medical device company in the field of brain surgery.
Clearpoint Neuro's ticker is CLPT
The company's shares trade on the NASDAQ stock exchange
They are based in Irvine, California
There are 11-50 employees working at Clearpoint Neuro
It is clearpointneuro.com
Clearpoint Neuro is in the Healthcare sector
Clearpoint Neuro is in the Medical Appliances & Equipment industry
The following five companies are Clearpoint Neuro's industry peers: